High EASIX Scores Linked to Greater Mortality in ICU Patients with Atrial Fibrillation: Study Shows
China: A recent retrospective study using the MIMIC-IV database has highlighted the prognostic value of the Endothelial Activation and Stress Index (EASIX) in critically ill patients diagnosed with atrial fibrillation (AF). The findings, published in the European Journal of Medical Research, reveal that EASIX is closely linked with the likelihood of death during hospitalization, as well as within 28 days and one year of ICU admission.
Atrial fibrillation is a common cardiac arrhythmia seen in intensive care settings and is often associated with poor clinical outcomes. The EASIX score, originally developed to reflect endothelial dysfunction and stress, was evaluated in this study to determine its potential as a mortality predictor in AF patients requiring intensive care.
Yu Xia, Department of Burn and Trauma Medicine, First Naval Hospital of Southern Theater Command, Zhanjiang, China, and colleagues analyzed data from 4,896 adult patients with AF sourced from the MIMIC-IV critical care database. The EASIX score was calculated based on three routine laboratory markers: lactate dehydrogenase (LDH), creatinine, and platelet count. To strengthen the statistical rigor, advanced methods like the Boruta algorithm and LASSO regression were employed to identify key variables, while Cox regression and logistic models assessed the predictive value of EASIX.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.